Last year, Cytosorbents Corp generated 35.59M USD for its biggest-performing segment, CytoSorb and other sales. The All Other made the largest contribution, accounting for 25.06M USD last year. For the latest quarter, Cytosorbents Corp reported the revenue of 9.48M USD for the period ending 2025-09-30, which came from the top-performing segment, CytoSorb and other sales. All Other contributed the highest revenue, at 6.89M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

CytoSorb and other sales

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

CytoSorb and other sales

35.59M(100.00%)

36.35M(100.00%)

34.69M(100.00%)

43.17M(100.00%)

41.00M(100.00%)

22.77M(100.00%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

All Other

Germany

United States

All other

Germany

United States

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

All Other

25.06M(67.62%)

--(--)

Germany

11.75M(31.71%)

--(--)

United States

249.00K(0.67%)

--(--)

All other

--(--)

22.39M(62.91%)

18.05M(49.67%)

15.82M(45.62%)

17.41M(40.34%)

17.85M(43.54%)

8.15M(35.80%)

Germany

--(--)

13.05M(36.66%)

12.96M(35.67%)

12.57M(36.23%)

21.01M(48.66%)

20.26M(49.40%)

14.40M(63.24%)

United States

--(--)

150.61K(0.42%)

5.33M(14.67%)

6.30M(18.16%)

4.75M(11.00%)

2.89M(7.06%)

220.10K(0.97%)